Sensus Healthcare, Inc. SRTS
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
4/9
Piotroski F — financial health
14.36
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $27.5M | -$7.7M | $11.9M | $332,000 | $48.1M |
| 2024 | $41.8M | $6.6M | $24.4M | -$1.1M | $55.8M |
| 2023 | $24.4M | $485,000 | $14.1M | -$2.4M | $48.8M |
| 2022 | $44.5M | $24.2M | $29.6M | -$1.6M | $48.1M |
| 2021 | $27.0M | $4.1M | $17.0M | -$414,000 | $26.0M |
| 2020 | $9.6M | -$6.8M | $5.2M | -$793,000 | $21.5M |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 14.36 (safe)
- Working capital / assets 0.776
- Retained earnings / assets 0.108
- EBIT / assets -0.194
- Equity / liabilities 9.734
Source: SEC EDGAR filings · CIK 0001494891 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.